Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DRIO NASDAQ:LUNG NASDAQ:OSRH NASDAQ:SKYA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRIODarioHealth$6.78+10.2%$7.48$5.84▼$17.74$49.53M1.1112,942 shs43,478 shsLUNGPulmonx$1.25$1.39$1.13▼$3.88$52.80M0.28495,457 shs4.12 million shsOSRHOSR$0.33+4.2%$0.50$0.31▼$1.57$11.72M0.614.06 million shs295,196 shsSKYASkyAI, Inc. Common Stock$1.09+14.7%$1.59$0.91▼$18.23$46.13M2.04483,540 shs484,415 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRIODarioHealth+1.49%-11.26%-18.11%-24.17%-55.82%LUNGPulmonx-10.07%-1.96%-20.38%+6.84%-52.47%OSRHOSR-4.87%-18.17%-35.23%-31.01%-74.35%SKYASkyAI, Inc. Common Stock-6.86%-19.49%-47.80%-39.87%-82.37%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDRIODarioHealth$6.78+10.2%$7.48$5.84▼$17.74$49.53M1.1112,942 shs43,478 shsLUNGPulmonx$1.25$1.39$1.13▼$3.88$52.80M0.28495,457 shs4.12 million shsOSRHOSR$0.33+4.2%$0.50$0.31▼$1.57$11.72M0.614.06 million shs295,196 shsSKYASkyAI, Inc. Common Stock$1.09+14.7%$1.59$0.91▼$18.23$46.13M2.04483,540 shs484,415 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDRIODarioHealth+1.49%-11.26%-18.11%-24.17%-55.82%LUNGPulmonx-10.07%-1.96%-20.38%+6.84%-52.47%OSRHOSR-4.87%-18.17%-35.23%-31.01%-74.35%SKYASkyAI, Inc. Common Stock-6.86%-19.49%-47.80%-39.87%-82.37%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDRIODarioHealth 2.00Hold$10.5054.98% UpsideLUNGPulmonx 2.43Hold$5.58331.15% UpsideOSRHOSR 1.00SellN/AN/ASKYASkyAI, Inc. Common Stock 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest OSRH, LUNG, DRIO, and SKYA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/14/2026DRIODarioHealth Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.00 ➝ $10.005/13/2026DRIODarioHealth TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$11.004/30/2026LUNGPulmonx D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$14.004/21/2026SKYASkyAI, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDRIODarioHealth$22.36M2.21N/AN/A$10.05 per share0.67LUNGPulmonx$90.50M0.60N/AN/A$1.31 per share0.99OSRHOSR$2.91M3.97N/AN/A$4.95 per share0.07SKYASkyAI, Inc. Common Stock$200K222.18N/AN/A$9.12 per share0.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDRIODarioHealth-$41.71M-$8.88N/AN/AN/A-192.23%-60.52%-37.08%8/11/2026 (Estimated)LUNGPulmonx-$54M-$1.30N/AN/AN/A-60.09%-92.94%-39.80%7/29/2026 (Estimated)OSRHOSR-$27.06M-$0.33N/AN/AN/A-363.26%-7.24%-5.41%N/ASKYASkyAI, Inc. Common Stock-$282.50M-$1.63N/AN/AN/AN/A-157.91%-154.40%9/2/2026 (Estimated)Latest OSRH, LUNG, DRIO, and SKYA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026SKYASkyAI, Inc. Common StockN/A-$1.19N/A-$1.19N/A$0.19 million5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.0880N/A$0.48 million4/29/2026Q1 2026LUNGPulmonx-$0.33-$0.33N/A-$0.33$20.43 million$20.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDRIODarioHealthN/AN/AN/AN/AN/ALUNGPulmonxN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ASKYASkyAI, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDRIODarioHealth0.503.072.62LUNGPulmonx0.814.914.04OSRHOSRN/A0.160.14SKYASkyAI, Inc. Common StockN/A8.288.08Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDRIODarioHealth33.39%LUNGPulmonx91.04%OSRHOSR55.30%SKYASkyAI, Inc. Common Stock17.17%Insider OwnershipCompanyInsider OwnershipDRIODarioHealth3.50%LUNGPulmonx6.80%OSRHOSR36.80%SKYASkyAI, Inc. Common Stock20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDRIODarioHealth2007.31 million7.06 millionNo DataLUNGPulmonx25042.24 million39.37 millionOptionableOSRHOSRN/A35.10 million22.19 millionN/ASKYASkyAI, Inc. Common Stock5542.32 million33.86 millionNot OptionableOSRH, LUNG, DRIO, and SKYA HeadlinesRecent News About These CompaniesSkyAI, Inc.: SkyAI Confirms Receipt of Unsolicited, Non-Binding Proposal from Forward IndustriesJune 16, 2026 | finanznachrichten.deUPDATED: Forward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)June 15, 2026 | globenewswire.comSkyAI receives unsolicited all-stock merger proposal from Forward IndustriesJune 15, 2026 | msn.comSkyAI Confirms Receipt of Unsolicited, Non-Binding Proposal from Forward IndustriesJune 15, 2026 | globenewswire.comForward Industries Announces Letter of Intent to Acquire SkyAI, Inc. (SKYA)June 15, 2026 | globenewswire.comSkyAI Inc.June 12, 2026 | money.usnews.comSharps Technology Appoints Arthur Levine as Chief Financial OfficerMay 29, 2026 | tipranks.comSharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global SouthMay 28, 2026 | markets.businessinsider.comSharps Technology Inc: Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury ExecutionMay 16, 2026 | finanznachrichten.deSharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury ExecutionMay 15, 2026 | prnewswire.comSharps Technology Inc: Sharps Technology Adopts Limited Duration Stockholder Rights PlanMay 15, 2026 | finanznachrichten.deSharps Technology Adopts Limited Duration Stockholder Rights PlanMay 14, 2026 | prnewswire.comSharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury StrategyApril 7, 2026 | theglobeandmail.comSharps Technology, Inc. Reports Financial Results for 2025 with Over 2 Million SOL and Expanded Partnerships in the Solana EcosystemApril 6, 2026 | quiverquant.comQSharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana EcosystemFebruary 25, 2026 | markets.businessinsider.comSharps Technology Appoints Interim Chief Financial Officer LevineFebruary 23, 2026 | tipranks.comHoldings Ltd Falconx Sells 239,588 Shares of Sharps Technology (NASDAQ:STSS) StockFebruary 14, 2026 | insidertrades.comSharps Technology and BitGo Announce Collaboration to Advance Solana Treasury StrategyFebruary 5, 2026 | globenewswire.comSharps Technology Inc: Sharps Technology Reports Strong Solana Staking IncomeJanuary 26, 2026 | finanznachrichten.deSharps Technology Reports Strong Solana Staking IncomeJanuary 26, 2026 | manilatimes.netMNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Under-the-Radar AI Stocks to Watch in JuneBy Thomas Hughes | May 31, 2026Mission Control: Floating In SpaceX's Record-Breaking OrbitBy Jeffrey Neal Johnson | June 15, 2026Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionBy Jeffrey Neal Johnson | June 11, 2026Micron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026Short Sellers Are Piling Into Wingstop, But Analysts See Big UpsideBy Jennifer Ryan Woods | June 10, 2026OSRH, LUNG, DRIO, and SKYA Company DescriptionsDarioHealth NASDAQ:DRIO$6.78 +0.63 (+10.16%) Closing price 03:59 PM EasternExtended Trading$6.90 +0.12 (+1.77%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Pulmonx NASDAQ:LUNG$1.25 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.28 +0.03 (+2.80%) As of 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.OSR NASDAQ:OSRH$0.33 +0.01 (+4.18%) Closing price 04:00 PM EasternExtended Trading$0.33 0.00 (-0.90%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.SkyAI, Inc. Common Stock NASDAQ:SKYA$1.09 +0.14 (+14.74%) As of 04:00 PM EasternSkyAI Inc is developing financial technology platforms focused on users in emerging markets. Its operations include the use of stablecoin-based payment infrastructure and artificial intelligence (AI) technologies to provide financial access, educational tools, and data analysis services for users in Asia, Latin America, and Africa. The company's platform will utilize the Solana blockchain network to support digital asset and on-chain data applications. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab's NASA Win Tests Key Support After Sharp Pullback BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout Palantir’s Valuation Problem Just Met 2 New Growth Catalysts Micron’s HBM Surge Could Redefine the AI Growth Story Carnival's Second Quarter: Is the Stock Still Complicated? Xcel Energy Stock Offers Stability as Electricity Demand Builds Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
